The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its ...

Bacteria-eating viruses called bacteriophages are drawing new interest, Lina Zeldovich writes in "The Living Medicine." ...

Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Children with Down syndrome are up to 150 times more likely to develop acute myeloid leukemia before age 5 and yet very ...

Celltrion (KRX:068270), a global biopharmaceutical leader, announced its acquisition of iQone Healthcare Switzerland, a specialty pharmaceutical company focused on distribution, sales, and marketing ...

It's also yielded a higher-than-expected positivity rate. "We have found with the study that we do have a high positivity ...

The study noted that while semaglutide drugs “substantially decreased” the risk of hospitalization, the results were not associated with suicide attempts. (Irwin, 11/13) Yahoo Finance: Hims & Hers ...

Aurinia Pharmaceuticals Reports Q3 and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development ...